V

Vericel Corp
D

VCEL

56.480
USD
1.53
(2.78%)
Market Closed
Volume
9,016
EPS
0
Div Yield
-
P/E
706
Market Cap
2,787,762,884
OverviewSignalsIdeasNews
Related Instruments
    A
    ABMD
    0
    (0%)
    0.000000 USD
    A
    ALGN
    -2.420
    (-1.13%)
    211.130 USD
    B
    BAX
    0.605
    (2.09%)
    29.525 USD
    BSX
    BSX
    0.320
    (0.36%)
    88.990 USD
    EW
    EW
    0.910
    (1.23%)
    74.820 USD
    ISRG
    ISRG
    1.09
    (0.21%)
    524.91 USD
    M
    MTD
    26.75
    (2.22%)
    1,232.41 USD
    RMD
    RMD
    5.790
    (2.50%)
    237.370 USD
    STE
    STE
    2.990
    (1.46%)
    207.410 USD
    TMO
    TMO
    7.55
    (1.46%)
    524.03 USD
    More
News

Title: Vericel Corp

Sector: Healthcare
Industry: Biotechnology
Vericel Corp is a fully integrated, commercial-stage biopharmaceutical company, specialized in various therapies for sports medicine and severe burn care markets. It markets two cell therapy products in the United States, MACI (autologous cultured chondrocytes on porcine collagen membrane) and Epicel (cultured epidermal autografts). The company operates in one reportable segment: the research, product development, manufacture, and distribution of patient-specific, expanded cellular therapies for use in the treatment of specific diseases.